Raymond James & Associates’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
CCM
Raymond James & Associates's CCAP Position: Q3 2024 in Review
Raymond James & Associates increased its Crescent Capital BDC (CCAP) stake by 37% in Q3 2024, buying an estimated $443K and bringing the position to 88,013 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.
Raymond James & Associates first reported a position in CCAP in Q1 2020 and has held it in 19 quarters since. The position peaked at $2.96M in Q4 2020. 82 funds tracked by Wall St. Rank hold CCAP as of Q3 2024.
- Raymond James & Associates held 88,013 shares of Crescent Capital BDC worth $1.63M as of Q3 2024.
- Raymond James & Associates bought 23,839 Crescent Capital BDC shares in Q3 2024, an estimated $443K.
- Crescent Capital BDC made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2347 holding.
- Raymond James & Associates first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 19 quarters since.
- Raymond James & Associates's Crescent Capital BDC position peaked at $2.96M in Q4 2020.
- 82 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.